Search - tctmd.com

Displaying 681 - 700 of 726

Sort: Relevancy | Date

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Daily News

DES Associated with Less Downstream Lesion Development than BMS

L.A. McKeown

November 04, 2011

News Daily News

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

L.A. McKeown

October 21, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Clinical Variables Added to Syntax Score Increases Predictive Ability

L.A. McKeown

September 30, 2011

News Daily News

IVUS Guidance of DES Implantation Improves Outcomes

September 28, 2011

News Daily News

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

L.A. McKeown

September 16, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Daily News

Selective Use of DES Saves Millions of Dollars a Year

Jason Kahn

August 15, 2011

News Daily News

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Jason Kahn

August 08, 2011

News Daily News

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Caitlin E. Cox

August 05, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

July 15, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

Advertisement

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

DES Associated with Less Downstream Lesion Development than BMS

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Clinical Variables Added to Syntax Score Increases Predictive Ability

IVUS Guidance of DES Implantation Improves Outcomes

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Long-term Antiplatelet Therapy: All Risk, No Benefit

New-Generation DES Reduce Restenosis, Stent Thrombosis

Selective Use of DES Saves Millions of Dollars a Year

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Women Have Less Neointimal Hyperplasia Than Men With ZES

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

DES Show Advantage over BMS for Heart Transplant Complication

EES Show Long-term Safety Advantage over SES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content